Ana səhifə

Section I: Surgical Biology Chapter 1: Inflammatory Response references


Yüklə 3.38 Mb.
səhifə4/55
tarix24.06.2016
ölçüsü3.38 Mb.
1   2   3   4   5   6   7   8   9   ...   55

Chapter 6: Shock




REFERENCES

  1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864, 1992. PUBMED Abstract

  2. American College of Surgeons: Advanced trauma life support (ATLS) student manual, ed 6, Chicago, 2002, American College of Surgeons.

  3. Acierno MJ, Labato MA: Hypertension in dogs and cats. Compend Contin Educ Pract Vet 26:336, 2004.

  4. Allen SE, Holm JL: Lactate: physiology and clinical utility. J Vet Emerg Crit Care 18:123, 2008.

  5. Beaulieu KE, Kerr CL, McDonell WN: Evaluation of a lithium dilution cardiac output technique as a method for measurement of cardiac output in anesthetized cats. Am J Vet Res 66:1639, 2005. PUBMED Abstract

  6. Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699, 2001. PUBMED Abstract

  7. Binns SH, Sisson DD, Buoscio DA, et al: Doppler ultrasonographic, oscillometric sphygmomanometric, and photoplethysmographic techniques for noninvasive blood pressure measurement in anesthetized cats. J Vet Intern Med 9:405, 1995. PUBMED Abstract

  8. Boag AK, Hughes D: Assessment and treatment of perfusion abnormalities in the emergency patient. Vet Clin North Am Small Anim Pract 35:319, 2005. PUBMED Abstract

  9. Boothe DM: Principles of antimicrobial therapy. Vet Clin North Am Small Anim Pract 36:1003, 2006. PUBMED Abstract

  10. Brady CA, Otto CM, Van Winkle TJ, et al: Severe sepsis in cats: 29 cases (1986–1998). J Am Vet Med Assoc 217:531, 2000. PUBMED Abstract

  11. Burkitt JM, Haskins SC, Nelson RW, et al: Relative adrenal insufficiency in dogs with sepsis. J Vet Intern Med 21:226, 2007. PUBMED Abstract

  12. Campbell VL: Anesthetic protocols for common emergencies. Vet Clin North Am Small Anim Pract 35:435, 2005. PUBMED Abstract

  13. Christopher MM, O’Neill S: Effect of specimen collection and storage on blood glucose and lactate concentrations in healthy, hyperthyroid and diabetic cats. Vet Clin Pathol 29:22, 2000. PUBMED Abstract

  14. Cooper MS, Stewart PM: Corticosteroid insufficiency in acutely ill patients. N Engl J Med 348:727, 2003. PUBMED Abstract

  15. Costello MF, Drobatz KJ, Aronson LR, et al: Underlying cause, pathophysiologic abnormalities, and response to treatment in cats with septic peritonitis: 51 cases (1990–2001). J Am Vet Med Assoc 225:897, 2004. PUBMED Abstract

  16. Creteur J: Muscle StO2 in critically ill patients. Curr Opin Crit Care 14:361, 2008. PUBMED Abstract

  17. Cronin L, Cook DJ, Carlet J, et al: Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 23:1430, 1995. PUBMED Abstract

  18. de Laforcade AM, Freeman LM, Shaw SP, et al: Hemostatic changes in dogs with naturally occurring sepsis. J Vet Intern Med 17:674, 2003. PUBMED Abstract

  19. de Papp E, Drobatz KJ, Hughes D: Plasma lactate concentration as a predictor of gastric necrosis and survival among dogs with gastric dilatation-volvulus: 102 cases (1995–1998). J Am Vet Med Assoc 215:49, 1999. PUBMED Abstract

  20. DeClue AE, Williams KJ, Sharp C, et al: Systemic response to low-dose endotoxin infusion in cats. Vet Immunol Immunopathol 132:167, 2009. PUBMED Abstract

  21. Dellinger RP, Levy MM, Carlet JM, et al: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36:296, 2008. PUBMED Abstract

  22. Dubin A, Estenssoro E, Murias G, et al: Effects of hemorrhage on gastrointestinal oxygenation. Intensive Care Med 27:1931, 2001. PUBMED Abstract

  23. Dunphy ED, Mann FA, Dodam JR: Comparison of unilateral versus bilateral nasal catheters for oxygen administration in dogs. J Vet Emerg Crit Care 12:245, 2002.

  24. Durkan S, Rozanski EA, Rush JE: Suspected relative adrenal insufficiency in a critically ill cat. J Vet Emerg Crit Care 17:197, 2007.

  25. Englehart MS, Schreiber MA: Measurement of acid-base resuscitation endpoints: lactate, base deficit, bicarbonate or what? Curr Opin Crit Care 12:569, 2006. PUBMED Abstract

  26. Evans GO: Plasma lactate measurements in healthy beagle dogs. Am J Vet Res 48:131, 1987. PUBMED Abstract

  27. Fahy BG, Sheehy AM, Coursin DB: Glucose control in the intensive care unit. Crit Care Med 37:1769, 2009. PUBMED Abstract

  28. Finfer S, Chittock DR, Su SY, et al: Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283, 2009. PUBMED Abstract

  29. Francis AH, Martin LG, Haldorson GJ, et al: Adverse reactions suggestive of type III hypersensitivity in six healthy dogs given human albumin. J Am Vet Med Assoc 230:873, 2007. PUBMED Abstract

  30. Giunti M, Otto CM: Intraosseous catheterization. In Silverstein DC, Hooper K, editors: Small animal critical care medicine, ed 1, St Louis, 2008, Saunders Elsevier, pp 263.

  31. Gunn SR, Pinsky MR: Implications of arterial pressure variation in patients in the intensive care unit. Curr Opin Crit Care 7:212, 2001. PUBMED Abstract

  32. Hall KE, Powell LL, Beilman GJ: Measurement of tissue oxygen saturation levels using portable near-infrared spectroscopy in clinically healthy dogs. J Vet Emerg Crit Care 18:594, 2008.

  33. Hameed SM, Cohn SM: Gastric tonometry: the role of mucosal pH measurement in the management of trauma. Chest 123:475S, 2003. PUBMED Abstract

  34. Hammond TN, Holm JL: Limited fluid volume resuscitation. Compend Contin Educ Vet 31:309, 2009. PUBMED Abstract

  35. Harper AM: Autoregulation of cerebral blood flow: influence of the arterial blood pressure on the blood flow through the cerebral cortex. J Neurol Neurosurg Psychiatry 29:398, 1966. PUBMED Abstract

  36. Haskins S, Pascoe PJ, Ilkiw JE, et al: Reference cardiopulmonary values in normal dogs. Comp Med 55:156, 2005. PUBMED Abstract

  37. Hess JR, Brohi K, Dutton RP, et al: The coagulopathy of trauma: a review of mechanisms. J Trauma 65:748, 2008. PUBMED Abstract

  38. Hochreiter M, Kohler T, Schweiger AM, et al: Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care 13:R83, 2009. PUBMED Abstract

  39. Hoffmann JJ: Neutrophil CD64: a diagnostic marker for infection and sepsis. Clin Chem Lab Med 47:903, 2009. PUBMED Abstract

  40. Houston DM, Ribble CS, Head LL: Risk factors associated with parvovirus enteritis in dogs: 283 cases (1982–1991). J Am Vet Med Assoc 208:542, 1996. PUBMED Abstract

  41. Hughes D, Rozanski ER, Shofer FS, et al: Effect of sampling site, repeated sampling, pH, and PCO2 on plasma lactate concentration in healthy dogs. Am J Vet Res 60:521, 1999. PUBMED Abstract

  42. Iwabuchi T, Watanabe K, Kutsuzawa T, et al: Lactate in the cerebrospinal fluid and pressure-flow relationships in canine cerebral circulation. Stroke 4:207, 1973. PUBMED Abstract

  43. King LG: Postoperative complications and prognostic indicators in dogs and cats with septic peritonitis: 23 cases (1989–1992). J Am Vet Med Assoc 204:407, 1994. PUBMED Abstract

  44. Kumar A, Parrillo JE: Shock: classification, pathophysiology, and approach to management. In Parillo JE, Dellinger RP, editors: Critical care medicine, ed 3, Philadelphia, 2007, Mosby.

  45. Kumar A, Roberts D, Wood KE, et al: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589, 2006. PUBMED Abstract

  46. Lagutchik MS, Ogilvie GK, Hackett TB: Increased lactate concentrations in ill and injured dogs. J Vet Emerg Crit Care 8:117, 1998.

  47. Leach RM, Treacher DF: The pulmonary physician and critical care. 6. Oxygen transport: the relation between oxygen delivery and consumption. Thorax 47:971, 1992.

  48. Levi M, van der Poll T, Buller HR: Bidirectional relation between inflammation and coagulation. Circulation 109:2698, 2004. PUBMED Abstract

  49. Levy MM, Fink MP, Marshall JC, et al: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 29:530, 2003. PUBMED Abstract

  50. Lima A, Bakker J: Noninvasive monitoring of peripheral perfusion. Intensive Care Med 31:1316, 2005. PUBMED Abstract

  51. Long KM, Kirby R: An update on cardiovascular adrenergic receptor physiology and potential pharmacological applications in veterinary critical care. J Vet Emerg Crit Care 18:2, 2008.

  52. Lotze MT, Zeh HJ, Rubartelli A, et al: The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev 220:60, 2007. PUBMED Abstract

  53. Marik PE, Bankov A: Sublingual capnometry versus traditional markers of tissue oxygenation in critically ill patients. Crit Care Med 31:818, 2003. PUBMED Abstract

  54. Marino PL: The ICU book, ed 3, Philadelphia, 2007, Lippincott Williams & Wilkins.

  55. Martinez-Albarran M, Perez-Molina JJ, Gallegos-Castorena S: Procalcitonin and C-reactive protein serum levels as markers of infection in a pediatric population with febrile neutropenia and cancer. Pediatr Hematol Oncol 26:414, 2009. PUBMED Abstract

  56. Mason DJ, O’Grady M, Woods JP, et al: Assessment of lithium dilution cardiac output as a technique for measurement of cardiac output in dogs. Am J Vet Res 62:1255, 2001. PUBMED Abstract

  57. Mazzaferro AM: Oxygen therapy. In Silverstein DC, Hooper K, editors: Small animal critical care medicine, ed 1, St Louis, 2008, Saunders Elsevier, pp 78.

  58. McMichael M: Ischemia-reperfusion injury: assessment and treatment, Part II. J Vet Emerg Crit Care 14:242, 2004.

  59. McMichael M, Lees GE, Hennessey J: Serial plasma lactate concentration in 68 puppies aged 4 to 80 days. J Vet Emerg Crit Care 15:17, 2005.

  60. McMichael M, Moore RM: Ischemia-reperfusion injury pathophysiology, Part I. J Vet Emerg Crit Care 14:231, 2004.

  61. Mittleman Boller E, Otto CM: Septic shock. In Silverstein DC, Hooper K, editors: Small animal critical care medicine, ed 1, St Louis, 2008, Saunders Elsevier, pp 459.

  62. Miyamoto T, Fujinaga T, Yamashita K, et al: Changes of serum cytokine activities and other parameters in dogs with experimentally induced endotoxic shock. Jpn J Vet Res 44:107, 1996. PUBMED Abstract

  63. Moeniralam HS, Bemelman WA, Romijn JA, et al: Origin of endotoxemia influences the metabolic response to endotoxin in dogs. J Surg Res 73:47, 1997. PUBMED Abstract

  64. Mosher P, Ross J Jr, McFate PA, et al: Control of coronary blood flow by an autoregulatory mechanism. Circ Res 14:250, 1964. PUBMED Abstract

  65. Muir W: Trauma: physiology, pathophysiology, and clinical implications. J Vet Emerg Crit Care 16:253, 2006.

  66. Nel M, Lobetti RG, Keller N, et al: Prognostic value of blood lactate, blood glucose, and hematocrit in canine babesiosis. J Vet Intern Med 18:471, 2004. PUBMED Abstract

  67. Nemzek JA, Agrodnia MD, Hauptman JG: Breed-specific pro-inflammatory cytokine production as a predisposing factor for susceptibility to sepsis in the dog. J Vet Emerg Crit Care 17:368, 2007.

  68. Neyrinck AP, Liu KD, Howard JP, et al: Protective mechanisms of activated protein C in severe inflammatory disorders. Br J Pharmacol 158:1034, 2009. PUBMED Abstract

  69. Oh JS, Kim SU, Oh YM, et al: The usefulness of the semiquantitative procalcitonin test kit as a guideline for starting antibiotic administration. Am J Emerg Med 27:859, 2009. PUBMED Abstract

  70. Pachtinger GE, Drobatz K: Assessment and treatment of hypovolemic states. Vet Clin North Am Small Anim Pract 38:629, 2008. PUBMED Abstract

  71. Parsons KJ, Owen LJ, Lee K, et al: A retrospective study of surgically treated cases of septic peritonitis in the cat (2000–2007). J Small Anim Pract 50:518, 2009. PUBMED Abstract

  72. Patel SA, Simon MC: Biology of hypoxia-inducible factor-2alpha in development and disease. Cell Death Differ 15:628, 2008. PUBMED Abstract

  73. Peyton JL, Burkitt JM: Critical illness-related corticosteroid insufficiency in a dog with septic shock. J Vet Emerg Crit Care (San Antonio) 19:262, 2009. PUBMED Abstract

  74. Prittie JE, Barton LJ, Peterson ME, et al: Pituitary ACTH and adrenocortical secretion in critically ill dogs. J Am Vet Med Assoc 220:615, 2002. PUBMED Abstract

  75. Rabuel C, Mebazaa A: Septic shock: a heart story since the 1960s. Intensive Care Med 32:799, 2006. PUBMED Abstract

  76. Rady MY: Possible mechanisms for the interaction of peripheral somatic nerve stimulation, tissue injury, and hemorrhage in the pathophysiology of traumatic shock. Anesth Analg 78:761, 1994. PUBMED Abstract

  77. Rand JS, Kinnaird E, Baglioni A, et al: Acute stress hyperglycemia in cats is associated with struggling and increased concentrations of lactate and norepinephrine. J Vet Intern Med 16:123, 2002. PUBMED Abstract

  78. Rau S, Kohn B, Richter C, et al: Plasma interleukin-6 response is predictive for severity and mortality in canine systemic inflammatory response syndrome and sepsis. Vet Clin Pathol 36:253, 2007. PUBMED Abstract

  79. Razminia M, Trivedi A, Molnar J, et al: Validation of a new formula for mean arterial pressure calculation: the new formula is superior to the standard formula. Catheter Cardiovasc Interv 63:419, 2004. PUBMED Abstract

  80. Reinhart K, Bloos F: The value of venous oximetry. Curr Opin Crit Care 11:259, 2005. PUBMED Abstract

  81. Reinhart K, Rudolph T, Bredle DL, et al: Comparison of central-venous to mixed-venous oxygen saturation during changes in oxygen supply/demand. Chest 95:1216, 1989. PUBMED Abstract

  82. Rivers E, Nguyen B, Havstad S, et al: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368, 2001. PUBMED Abstract

  83. Rothe CF, Nash FD, Thompson DE: Patterns in autoregulation of renal blood flow in the dog. Am J Physiol 220:1621, 1971. PUBMED Abstract

  84. Ruthrauff CM, Smith J, Glerum L: Primary bacterial septic peritonitis in cats: 13 cases. J Am Anim Hosp Assoc 45:268, 2009. PUBMED Abstract

  85. Sakaue Y, Nezu Y, Yanagisawa S, et al: Effects of continuous low-dose infusion of lipopolysaccharide on expression of E-selectin and intercellular adhesion molecule-1 messenger RNA and neutrophil accumulation in specific organs in dogs. Am J Vet Res 66:1259, 2005. PUBMED Abstract

  86. Scheinman MM, Brown MA, Rapaport E: Critical assessment of use of central venous oxygen saturation as a mirror of mixed venous oxygen in severely ill cardiac patients. Circulation 40:165, 1969. PUBMED Abstract

  87. Schutzer KM, Haglund U, Falk A: Cardiopulmonary dysfunction in a feline septic shock model: possible role of leukotrienes. Circ Shock 29:13, 1989. PUBMED Abstract

  88. Schutzer KM, Larsson A, Risberg B, et al: Lung protein leakage in feline septic shock. Am Rev Respir Dis 147:1380, 1993. PUBMED Abstract

  89. Silverstein DC, Pruett-Saratan A, 2nd, Drobatz KJ: Measurements of microvascular perfusion in healthy anesthetized dogs using orthogonal polarization spectral imaging. J Vet Emerg Crit Care (San Antonio) 19:579, 2009. PUBMED Abstract

  90. Silverstein DC, Waddell LS, Drobatz K: Vasopressin therapy in dogs with dopamine-resistant hypotension and vasodilatory shock. J Vet Emerg Crit Care 17:399, 2007.

  91. Silverstein DS, Otto CM: Sepsis. In Greene CE, editor: Infectious diseases of the dog and cat, St Louis, 2010, Elsevier.

  92. Taylor RW, Jr, Calvin JE, Matuschak GM: Pulmonary artery catheter consensus conference: the first step. Crit Care Med 25:2064, 1997. PUBMED Abstract

  93. Trow AV, Rozanski EA, Delaforcade AM, et al: Evaluation of use of human albumin in critically ill dogs: 73 cases (2003–2006). J Am Vet Med Assoc 233:607, 2008. PUBMED Abstract

  94. Van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in the critically ill patient. N Engl J Med 345:1359, 2001. PUBMED Abstract

  95. Van der Linden P, Rausin I, Deltell A, et al: Detection of tissue hypoxia by arteriovenous gradient for PCO2 and pH in anesthetized dogs during progressive hemorrhage. Anesth Analg 80:269, 1995. PUBMED Abstract

  96. Waddell LS, Brady CA, Drobatz KJ: Risk factors, prognostic indicators, and outcome of pyothorax in cats: 80 cases (1986–1999). J Am Vet Med Assoc 221:819, 2002. PUBMED Abstract

  97. Walmsley SR, McGovern NN, Whyte MK, et al: The HIF/VHL pathway: from oxygen sensing to innate immunity. Am J Respir Cell Mol Biol 38:251, 2008. PUBMED Abstract

  98. Wang GL, Jiang BH, Rue EA, et al: Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 92:5510, 1995. PUBMED Abstract

  99. Weiss DJ, Welle M, Mortiz A, et al: Evaluation of leukocyte cell surface markers in dogs with septic and nonseptic inflammatory diseases. Am J Vet Res 65:59, 2004. PUBMED Abstract

  100. Wilkins PA, Otto CM, Baumgardner JE: Acute lung injury and acute respiratory distress syndromes in veterinary medicine: consensus definitions. J Vet Emerg Crit Care 17:333, 2007.

  101. Gauer OH: Kreislauf des Blutes. In Landois L, Rosemann H-H, editors: Lehrbuch der physiologie des Menschen, Munchen and Berlin, 1960, Von Urban and Schwarzenberg, pp 95.

  102. Nelson DP, King CE, Dodd SL, et al: Systemic and intestinal limits of O2 extraction in the dog. J Appl Physiol 63:387, 1987. PUBMED Abstract

  103. Prittie J: Optimal endpoints of resuscitation and early goal-directed therapy. J Vet Emerg Crit Care 16:329, 2006.

Chapter 7: Bleeding and Hemostasis



REFERENCES

  1. Abraham E, Reinhart K, Svoboda P, et al: Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study. Crit Care Med 29:2081, 2001. PUBMED Abstract

  2. Abraham E, Reinhart K, Opal S, et al: Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 290:238, 2003. PUBMED Abstract

  3. Abrams-Ogg ACG, Kruth SA, Carter RF, et al: Preparation and transfusion of canine platelet concentrates. Am J Vet Res 54:635, 1993. PUBMED Abstract

  4. Abrams-Ogg ACG: Triggers for prophylactic use of platelet transfusions and optimal platelet dosing in thrombocytopenic dogs and cats. Vet Clin N Am Small Anim 33:1401, 2003.

  5. Acka S, Haji MP, de Medonca A, et al: The time course of platelet counts in critically ill patients. Crit Care Med 30:753, 2002.

  6. Alwood AJ, Downend AB, Simpson SA, et al: Pharmacokinetics of dalteparin and enoxaparin in healthy cats (abstract). J Vet Emerg Crit Care 15:S1, 2005.

  7. Alwood AJ, Downend AB, Brooks MB, et al: Anticoagulant effects of low-molecular-weight heparins in healthy cats. J Vet Intern Med 21:378, 2007. PUBMED Abstract

  8. American Society of Anesthesiologists Task Force on Blood Component Therapy: Practice guidelines for blood component therapy. Anesthesiology 84:732, 1996.

  9. Amirkhosravi A, Meyer T, Amaya M, et al: The role of tissue factor pathway inhibitor in tumor growth and metastasis. Semin Thromb Hemost 33:643, 2007. PUBMED Abstract

  10. Anand SS, Bates S, Ginsberg JS, et al: Recurrent venous thrombosis and heparin therapy: an evaluation of the importance of early activated partial thromboplastin times. Arch Intern Med 159:2029, 1999. PUBMED Abstract

  11. Anderson FA, Spencer FA: Risk factors for venous thromboembolism. Circulation 107:I9, 2003. PUBMED Abstract

  12. Angelos MG, Hamilton GC: Coagulation studies: prothrombin time, partial thromboplastin time, bleeding time. Emerg Med Clin North Am 4:95, 1986. PUBMED Abstract

  13. Ansell J, Hirsh J, Poller L, et al: The pharmacology and management of vitamin K antagonists: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:204S, 2004. PUBMED Abstract

  14. Antithrombotic Trialists’ Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324:71, 2002.

  15. Appleman EH, Sachaias BS, Patel R, et al: Cryopreservation of canine platelets. J Vet Intern Med 23:138, 2009. PUBMED Abstract

  16. Atkins CE, Gallo AM, Kurzman ID, et al: Risk factors, clinical signs, and survival in cats with a clinical diagnosis of idiopathic hypertrophic cardiomyopathy: 74 cases (1985–1989). J Am Vet Med Assoc 201:613, 1992. PUBMED Abstract

  17. Badylak SF, Dodds WJ, Van Vleet JF, et al: Plasma coagulation factor abnormalities in dogs with naturally occurring hepatic disease. Am J Vet Res 44:2336, 1983. PUBMED Abstract

  18. Badylak SF: Coagulation disorders and liver disease. Vet Clin North Am Small Anim Pract 18:87, 1988. PUBMED Abstract

  19. Baker WF: Diagnosis of deep venous thrombosis and pulmonary embolism. Med Clin N Am 82:459, 1998. PUBMED Abstract

  20. Bakhtiari K, Meijers JCM, de Jonge E, et al: Prospective validation of the international society of thrombosis and haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 32: 2416, 2004. PUBMED Abstract

  21. Bateman SW, Mathews KA, Abrams-Ogg ACG: Disseminated intravascular coagulation in dogs: review of the literature. J Vet Emerg Crit Care 8:29, 1998.

  22. Bateman SW, Mathews KA, Abrams-Ogg AC, et al: Diagnosis of disseminated intravascular coagulation in dogs admitted to an intensive care unit. J Am Vet Med Assoc 215:798, 1999. PUBMED Abstract

  23. Bateman SW: Hypercoagulable states. In Silverstein DS, Hopper K, editors: Small animal critical care medicine, St Louis, 2009, Saunders Elsevier, pp 503.

  24. Bauer KA, Rosenberg RD: The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic activation. Blood 70:343, 1987. PUBMED Abstract

  25. Bauer KA, Rosenberg RD: Role of antithrombin III as a regulator of in vivo coagulation. Semin Hematol 28:10, 1991. PUBMED Abstract

  26. Becker DM, Philbrick JT, Bachhuber TL, et al: D-dimer testing and acute venous thromboembolism. Arch Intern Med 156:939, 1996. PUBMED Abstract

  27. Ben S, Ni S, Shen H, et al: The dynamic changes of LDH isoenzyme 3 and D-dimers following pulmonary thromboembolism in the canine. Thrombosis Res 120:575, 2007. PUBMED Abstract

  28. Bernard GR, Ely EW, Wright TJ, et al: Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis. Crit Care Med 29:2051, 2001. PUBMED Abstract

  29. Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699, 2001b. PUBMED Abstract

  30. Bick RL, Kaplan H: Syndromes of thrombosis and hypercoagulability: congenital and acquired causes of thrombosis. Med Clin N Am 82:409, 1998. PUBMED Abstract

  31. Bick RL, Arun B, Frenkel EP: Disseminated intravascular coagulation: clinical and pathophysiologic mechanisms and manifestations. Haemostasis 29:111, 1999. PUBMED Abstract

  32. Bijsterveld NR, Moons AH, Meijers JC, et al: Rebound thrombin generation after heparin therapy in unstable angina: a randomized comparison between unfractionated and low-molecular-weight heparins. J Am Coll Cardiol 39:811, 2002. PUBMED Abstract

  33. Bick RF: Clinical relevance of antithrombin III. Semin Thromb Haemost 8:276, 1982.

  34. Bick RL, Haas SK: International consensus recommendations: summary statement and additional suggested guidelines. Med Clin N Am 82:613, 1998. PUBMED Abstract

  35. Bliss SP, Bliss SK, Harvey HJ: Use of recombinant tissue-plasminogen activator in a dog with chylothorax secondary to catheter-associated thrombosis of the cranial vena cava. J Am Anim Hosp Assoc 38:431, 2002. PUBMED Abstract

  36. Bode AP, Fischer TH: Lyophilized platelets: 50 years in the making. Artif Cells Blood Substit Immobil Biotechnol 35:125, 2007. PUBMED Abstract

  37. Bode AP, Lust RM, Read MS, et al: Correction of the bleeding time with lyophilized platelet infusions in dogs on cardiopulmonary bypass. Clin Appl Thromb Hemost 14:38, 2008. PUBMED Abstract

  38. Boffard KD, Riou B, Warren B, et al: Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 59:8, 2005. PUBMED Abstract

  39. Boisvert AM, Swenson CL, Haines CJ: Serum and plasma latex agglutination tests for detection of fibrin(ogen) degradation products in clinically ill dogs. Vet Clin Pathol 30:133, 2001. PUBMED Abstract

  40. Boswood A, Lamb CR, White RN: Aortic and iliac thrombosis in six dogs. J Small Anim Pract 41:109, 2000. PUBMED Abstract

  41. Boudreaux MK: Acquired platelet dysfunction. In Feldman BF, Zinkl JG, Jain NC, editors: Schalm’s veterinary hematology, ed 5, Philadelphia, 2000, Lippincott Williams & Wilkins, pp 496. PUBMED Abstract

  42. Boutet P, Heath F, Archer J, et al: Comparison of quantitative immunoturbidometric and semiquantitative latex-agglutination assays for D-dimer measurement in canine plasma. Vet Clin Pathol 38:78, 2009. PUBMED Abstract

  43. Brainard BM, Meredith CP, Callan MB, et al: Changes in platelet function, hemostasis, and prostaglandin expression after treatment with nonsteroidal anti-inflammatory drugs with various cyclooxygenase selectivities in dogs. Am J Vet Res 68:251, 2007. PUBMED Abstract

  44. Brainard BM: Viscoelastic coagulation monitoring. In Proceedings of the 15th International Veterinary Emergency and Critical Care Symposium (VECCS), San Antonio, Texas, 2009, pp 501.

  45. Brazzell JL, Borjesson DL: Evaluation of plasma antithrombin activity and D-dimer concentration in populations of healthy cats, clinically ill cats, and cats with cardiomyopathy. Vet Clin Pathol 36:79, 2007. PUBMED Abstract

  46. Breuhl EL, Moore G, Brooks MB, et al: A prospective study of unfractionated heparin therapy in dogs with primary immune-mediated hemolytic anemia. J Am Anim Hosp Assoc 45:125, 2009. PUBMED Abstract

  47. Brinkhous KM, Hedner U, Garris GB, et al: Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease. Proc Natl Acad Sci U S A 86:1382, 1989. PUBMED Abstract

  48. Brohi K, Singh J, Heron M, et al: Acute traumatic coagulopathy. J Trauma 54:1127, 2003. PUBMED Abstract

  49. Brohi K, Cohen MJ, Ganter MT, et al: Acute traumatic coagulopathy: initiated by hypoperfusion, modulated through the protein C pathway? Ann Surg 245: 812, 2007. PUBMED Abstract

  50. Brohi K, Cohen MJ, Ganter MT, et al: Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma 64:1211, 2008. PUBMED Abstract

  51. Brookenthal KR, Freedman KB, Lotke PA, et al: A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty. J Arthroplasty 16:293, 2001. PUBMED Abstract

  52. Brooks M, Dodds WJ, Raymond SL: Epidemiologic features of von Willebrand’s disease in Doberman pinschers, Scottish terriers, and Shetland sheepdogs: 260 cases (1984–1988). J Am Vet Med Assoc 200:1123, 1992. PUBMED Abstract

  53. Brooks M, Catalfamo J: Buccal mucosal bleeding time is prolonged in canine models of primary hemostatic disorders. Thromb Haemost 70:777, 1993. PUBMED Abstract

  54. Brooks M, Raymond S, Catalfamo J: Severe, recessive von Willebrand’s disease in German wirehaired pointers. J Am Vet Med Assoc 209:926, 1996. PUBMED Abstract

  55. Brooks M: Transfusion of plasma and plasma derivatives. In Feldman BF, Zinkl JG, Jain NC, editors: Schalm’s veterinary hematology, ed 5, Philadelphia, 2000, Lippincott Williams and Wilkins, pp 838.

  56. Brooks M: Von Willebrand disease. In Feldman BF, Zinkl JG, Jain NC, editors: Schalm’s veterinary hematology, ed 5, Philadelphia, 2000, Lippincott Williams and Wilkins, pp 509.

  57. Brooks M, Spagnoletti-DeWilde, LS: Feline factor XII deficiency. Compend Contin Educ 28:148, 2006.

  58. Brooks MB, Catalfamo JL: Platelet dysfunction. In Bonagura JD, Twedt DC, editors: Kirk’s current veterinary therapy, ed 14, St Louis, 2009, Saunders Elsevier, pp 292.

  59. Brown SJ, Simpson KW, Baker S, et al: Macrothrombocytosis in Cavalier King Charles spaniels. Vet Rec 135:281, 1994. PUBMED Abstract

  60. Brummel-Zieldins K, Whelihan MF, Zieldins EG, et al: The resuscitative fluid you choose may potentiate bleeding. J Trauma 61:1350, 2006. PUBMED Abstract

  61. Buchanan JW, Beardow AW, Sammarco CD: Femoral artery occlusion in Cavalier King Charles spaniels. J Am Vet Med Assoc 211:872, 1997. PUBMED Abstract

  62. Buller HR, Ten Cate JW: Acquired antithrombin III deficiency: laboratory diagnosis, incidence, clinical implications, and treatment with antithrombin III concentrate. Am J Med 87:44S, 1989. PUBMED Abstract

  63. Bunch SE, Metcalf MR, Crane SW, et al: Idiopathic pleural effusion and pulmonary thromboembolism in a dog with autoimmune hemolytic anemia. J Am Vet Med Assoc 195:1748, 1989. PUBMED Abstract

  64. Caine GJ, Stonelake PS, Lip GYH, et al: The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia 4:465, 2002. PUBMED Abstract

  65. Caldin M, Furlanello T, Lubas G: Validation of an immunoturbidometric D-dimer assay in canine citrated plasma. Vet Clin Pathol 29:51, 2000. PUBMED Abstract

  66. Califf RM, Fortin DF, Tenaglia AN, et al: Clinical risks of thrombolytic therapy. Am J Cardiol 69:12A, 1992. PUBMED Abstract

  67. Callan MB, Appleman EH, Shofer FS, et al: Clinical and clinicopathologic effects of plateletpheresis on healthy donor dogs. Transfusion 48:2214, 2008. PUBMED Abstract

  68. Callan MB, Appleman EH, Sachais BS: Canine platelet transfusions. J Vet Emerg Crit Care 19:401, 2009. PUBMED Abstract

  69. CAPRIE Steering Committee: A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348:1329, 1996.

  70. Carr JM, Kuskall MS, Kaye JA, et al: Efficacy of platelet transfusions in immune thrombocytopenia. Am J Pathol 80:1051, 1986. PUBMED Abstract

  71. Carr AP, Panciera DL, Kidd L: Prognostic factors for mortality and thromboembolism in canine immune-mediated hemolytic anemia: a retrospective study of 72 dogs. J Vet Intern Med 16:504, 2002. PUBMED Abstract

  72. Carr AP, Nibblett BM, Panciera DL: Von Willebrand’s disease and other hereditary coagulopathies. In Bonagura JD, Twedt DC, editors: Kirk’s current veterinary therapy, ed 14, St Louis, 2009, Saunders Elsevier, pp 277.

  73. Catella-Lawson F, MacAdam B, Morrison BW, et al: Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J Pharmacol Exp Ther 289:735, 1999. PUBMED Abstract

  74. Cayley WE: Preventing deep vein thrombosis in hospital inpatients. BMJ 335:147, 2007. PUBMED Abstract

  75. Charbit B, Mandelbrot L, Samain E, et al: PPH study group: the decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 5:266, 2007. PUBMED Abstract

  76. Chee YL, Crawford JC, Watson HG, et al: Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures: British Committee for Standards in Haematology. Br J Haematol 140:496, 2008. PUBMED Abstract

  77. Ching YN, Myers KM, Brassard JA, et al: Effect of cryoprecipitate and plasma on plasma von Willebrand factor multimeters and bleeding time in Doberman Pinschers with type-I von Willebrand’s disease. Am J Vet Res 55:102, 1994. PUBMED Abstract

  78. Clare AC, Kraje BJ: Use of recombinant tissue-plasminogen activator for aortic thrombolysis in a hypoproteinemic dog. J Am Vet Med Assoc 212:539, 1998. PUBMED Abstract

  79. Coats TJ, Brazil E, Heron M, et al: Impairment of coagulation by commonly used resuscitation fluids in human volunteers. Emerg Med J 23:846, 2006. PUBMED Abstract

  80. Collen D, Lijnen JD: Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 78:3114, 1991. PUBMED Abstract

  81. Columbus Investigators: Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 337:657, 1997.

  82. Cook AK, Cowgill LD: Clinical and pathologic features of protein-losing glomerular disease in the dog: a review of 137 cases (1985–1992). J Am Anim Hosp Assoc 32:313, 1996. PUBMED Abstract

  83. Cooper E: Antifibrinolytics: a role in veterinary medicine? In Proceedings of the 14th International Veterinary Emergency and Critical Care Symposium (VECCS), San Antonio, Texas, 2008, pp 487.

  84. Coppell JA, Thalheimer U, Zambruni A, et al: The effects of unfractionated heparin, low molecular weight heparin and danaparoid on the thromboelastogram (TEG): an in-vitro comparison of standard and heparinase-modified TEGs with conventional coagulation assays. Blood Coagul Fibrinolysis 17:97, 2006. PUBMED Abstract

  85. Cosgriff N, Moore EE, Sauaia A, et al: Predicting life-threatening coagulopathy in the massively transfused trauma patient: hypothermia and acidosis revisited. J Trauma 58:1002, 1997. PUBMED Abstract

  86. Cosmi B, Fredengurgh JC, Rischke J, et al: Effect of nonspecific binding to plasma proteins on the antithrombin activities of unfractionated heparin, low molecular weight heparin and dermatan sulfate. Circulation 95:118, 1997. PUBMED Abstract

  87. Cosmi B, Palareti G: Oral anticoagulant therapy in venous thromboembolism. Semin Vasc Med 3:303, 2003. PUBMED Abstract

  88. Couto CG, Lara A, Iazbik MC, et al: Evaluation of platelet aggregation using a point-of-care instrument in retired racing Greyhounds. J Vet Intern Med 20:365, 2006. PUBMED Abstract

  89. CURE Steering Committee: Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345:494, 2001.

  90. Currie LM, Livesey SA, Harper JR, et al: Cryopreservation of single donor platelets with a reduced dimethyl sulfoxide concentration by the addition of second messenger effectors: enhanced retention of in vitro functional activity. Transfusion 38:160, 1998. PUBMED Abstract

  91. Dagi TF: The management of postoperative bleeding. Surg Clin N Am 85:1191, 2005. PUBMED Abstract

  92. Dantzker DR, Wagner PD, Tornabene VW, et al: Gas exchange after pulmonary thromboembolization in dogs. Circ Res 42:92, 1978. PUBMED Abstract

  93. Davi G, Patrono C: Platelet activation and atherothrombosis. N Engl J Med 357:2482, 2007. PUBMED Abstract

  94. Davidson BL, Rozanski EA, Tidwell AS, et al: Pulmonary thromboembolism in a heartworm-positive cat. J Vet Intern Med 20:1037, 2006. PUBMED Abstract

  95. de Laforcade AA, Freeman LA, Shaw SP, et al: Hemostatic changes in dogs with naturally occurring sepsis. J Vet Intern Med 17:674, 2003. PUBMED Abstract

  96. Despotis GJ, Levine V, Saleem R, et al: Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomized controlled trial. Lancet 354:106, 1999. PUBMED Abstract

  97. Dewhurst E, Cue S, Crawford E, et al: A retrospective study of canine D-dimer concentrations measured using an immunometric “point-of-care” test. J Small Anim Pract 49:344, 2008. PUBMED Abstract

  98. Diquelou A, Barbaste C, Gabaig AM, et al: Pharmacokinetics and pharmacodynamics of a therapeutic dose of unfractionated heparin (200 u/kg) administered subcutaneously or intravenously to healthy dogs. Vet Clin Pathol 34:237, 2005. PUBMED Abstract

  99. Dobrovolsky AB, Tataeva EV: The fibrinolysis system: regulation of activity and physiologic functions of its main components. Biochemistry 67:116, 2002. PUBMED Abstract

  100. Dodds WJ: Other hereditary coagulopathies. In Feldman BF, Zinkl JG, Jain NC, editors: Schalm’s veterinary hematology, ed 5, Philadelphia, 2000, Lippincott Williams Wilkins, pp 1030.

  101. Donahue SM, Otto CM: Thromboelastography: a tool for measuring hypercoagulability, hypocoagulability, and fibrinolysis. J Vet Emerg Crit Care 15:9, 2005.

  102. Donati MB, Falanga A: Pathogenetic mechanisms of thrombosis in malignancy. Acta Haematologica 106:18, 2001. PUBMED Abstract

  103. Du Toit H, Coetzee AR, Chalton DO: Heparin treatment in thrombin-induced disseminated intravascular coagulation in the baboon. Crit Care Med 19:1195, 1991. PUBMED Abstract

  104. Ejlersen E, Melsen T, Ingerslev J, et al: Recombinant activated factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from esophageal varices. Scand J Gastroenterol 36:1081, 2001. PUBMED Abstract

  105. Engelman DT, Gabram SG, Allen L, et al: Hypercoagulability following multiple trauma. World J Surg 20:5, 1996. PUBMED Abstract

  106. Esmon CT: Role of coagulation inhibitors in inflammation. Thromb Haemost 86:51, 2001. PUBMED Abstract

  107. Esmon CT: Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation. Crit Care Med 29:S48, 2001. PUBMED Abstract

  108. Esmon CT: The protein C pathway. Chest 124:26S, 2003. PUBMED Abstract

  109. Esmon CT: The interactions between inflammation and coagulation. Br J Haematol 131:417, 2005. PUBMED Abstract

  110. Estrin MA, Wehausen CE, Jessen CR, et al: Disseminated intravascular coagulation in cats. J Vet Intern Med 20:1334, 2006. PUBMED Abstract

  111. Feinstein DI: Diagnosis and management of disseminated intravascular coagulation: the role of heparin therapy. Blood 60:284, 1982. PUBMED Abstract

  112. Feldman BF, Madewell BR, O’Neill S: Disseminated intravascular coagulation: antithrombin, plasminogen, and coagulation abnormalities in 41 dogs. J Am Vet Med Assoc 179:151, 1981. PUBMED Abstract

  113. Feldman EC, Nelson RW: Canine hyperadrenocorticism. In Feldman EC, Nelson RW, editors: Canine and feline endocrinology and reproduction, ed 2, St Louis, 2004, WB Saunders, pp 252.

  114. Fenger-Eriksen C, Lindberg-Larsen M, Christensen AQ, et al: Fibrinogen concentrate substitution therapy in patients with massive hemorrhage and low plasma fibrinogen concentrations. Br J Anaesth 101:769, 2008. PUBMED Abstract

  115. Fenger-Eriksen C, Tonnesen E, Ingerslev J, et al: Mechanisms of hydroxyethyl starch induced dilutional coagulopathy. J Thromb Haemost 7:1099, 2009. PUBMED Abstract

  116. Fenger-Eriksen C, Ingerslev J, Sorensen B: Fibrinogen concentrate—a potential universal hemostatic agent. Expert Opin Biol Ther 9:1325, 2009. PUBMED Abstract

  117. Fenger-Eriksen C, Jensen TM, Kristensen BS, et al: Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethel starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled trial. J Thromb Haemost 7:795, 2009. PUBMED Abstract

  118. Fluckiger MA, Gomez JA: Radiographic findings in dogs with spontaneous pulmonary thrombosis or embolism. Vet Radiol 25:124, 1984.

  119. Franchini M, Zaffanello M, Veneri D: Recombinant factor VIIa: an update on its clinical use. Thromb Haemost 93:1027, 2005. PUBMED Abstract

  120. Franchini M: The use of recombinant factor VII in platelet disorders: a critical review of the literature. Blood Transfus 7:24, 2009. PUBMED Abstract

  121. Frank JR, Nutter FB, Kyles AE, et al: Systemic arterial dirofilariasis in five dogs. J Vet Intern Med 11:189, 1997. PUBMED Abstract

  122. Furie B, Furie BC: Mechanisms of thrombus formation. N Engl J Med 359:938, 2008. PUBMED Abstract

  123. Ganter MT, Hofer CK: Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 106:1366, 2008. PUBMED Abstract

  124. Geerts WH, Pineo GF, Heit JA, et al: Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:338S, 2004. PUBMED Abstract

  125. Ginsberg JS, Gent M, Turkstra F, et al: Postthrombotic syndrome after hip or knee arthroplasty: a cross-sectional study. Arch Intern Med 160:669, 2000. PUBMED Abstract

  126. Goldhaber SZ: Pulmonary embolism. N Engl J Med 339:93, 1998. PUBMED Abstract

  127. Goldhaber SZ: Echocardiography in the management of pulmonary embolism. Ann Intern Med 136:691, 2002. PUBMED Abstract

  128. Goldhaber SZ: Perspective: thrombolysis for pulmonary embolism. N Engl J Med 347:1131, 2002.

  129. Goncalves R, Penderis J, Chang YP, et al: Clinical and neurologic characteristics of aortic thromboembolism in dogs. J Small Anim Pract 49:178, 2008. PUBMED Abstract

  130. Goodnight SH, Hathaway WE: Disorders of hemostasis and thrombosis: a clinical guide, New York, 2001, McGraw-Hill.

  131. Graham HA, Leib MS: Effects of prednisone alone or prednisone with ultralow-dose aspirin on the gastroduodenal mucosa of healthy dogs. J Vet Intern Med 23:482, 2009. PUBMED Abstract

  132. Granger CB, Miller JM, Bovill EG, et al: Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes. Circulation 91:1929, 1995. PUBMED Abstract

  133. Green RA, Kabal AL: Hypercoagulable state in three dogs with nephrotic syndrome: role of acquired antithrombin III deficiency. J Am Vet Med Assoc 181:914, 1982. PUBMED Abstract

  134. Greene CE, Meriwether E: Activated partial thromboplastin time and activated coagulation time in monitoring heparinized cats. Am J Vet Res 43:1473, 1982. PUBMED Abstract

  135. Gregory CR, Kyles AE, Bernsteen L, et al: Results of clinical renal transplantation in 15 dogs using triple drug immunosuppressive therapy. Vet Surg 35:105, 2006. PUBMED Abstract

  136. Griffin A, Callan MB, Shofer ES, et al: Evaluation of a canine D-dimer point-of-care test kit for use in samples obtained from dogs with disseminated intravascular coagulation, thromboembolic disease, and hemorrhage. Am J Vet Res 64:1562, 2003. PUBMED Abstract

  137. Grindem CB, Breitschwerdt EB, Corbett WT, et al: Epidemiologic survey of thrombocytopenia in dogs: a report on 987 cases. Vet Clin Pathol 20:38, 1991. PUBMED Abstract

  138. Gunter OL, Au BK, Isbell JM, et al: Optimizing outcomes in damage control resuscitation: identifying blood product ratios associated with improved survival. J Trauma 65:527, 2008. PUBMED Abstract

  139. Haas T, Fries D, Velik-Salchner C, et al: The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution. Anesth Analg 106:1360, 2008. PUBMED Abstract

  140. Hackner SG: Pulmonary thromboembolism. In King LG, editor: Textbook of respiratory medicine of the dog and cat, Philadelphia, 2004, WB Saunders, pp 526.

  141. Hamel-Jolette A, Dunn M, Bedard C: Plateletworks: a screening assay for clopidogrel therapy monitoring in healthy cats. Can J Vet Res 73:73, 2009. PUBMED Abstract

  142. Handoll HH, Farrar MJ, McBirnie J, et al: Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures. Cochrane Database Syst Rev CD000305, 2002. PUBMED Abstract

  143. Hardie EM, Spaulding K, Malarkey DE: Splenic infarction in 16 dogs: a retrospective study. J Vet Intern Med 9:141, 1995. PUBMED Abstract

  144. Harnagle SH, Hornof WJ, Koblick PD, et al: The use of 99mTc radioaerosol ventilation and macroaggregated albumin perfusion imaging for the detection of pulmonary emboli in the dog. Vet Radiol 30:22, 1989.

  145. Harpster NK, Baty CJ: Warfarin therapy for the cat at risk for thromboembolism. In Bonagura JD, Kirk RW, editors: Current veterinary therapy, ed 12, Philadelphia, 1995, WB Saunders, pp 868.

  146. Hazelzet JA: Levels of protein C and activated protein C: what do they mean? Crit Care 10:126, 2006. PUBMED Abstract

  147. Hedner U, Martinsson G, Bergqvist D: Influence of operative trauma on factor XII and inhibitor of plasminogen activator. Haemostasis 13:219, 1983. PUBMED Abstract

  148. Helenski CA, Ross JN: Platelet aggregation in feline cardiomyopathy. J Vet Intern Med 1:24, 1987. PUBMED Abstract

  149. Hellebrekers LJ, Slappendal RJ, van den Brom WE: Effect of sodium heparin and antithrombin III concentration on activated partial thromboplastin time in the dog. Am J Vet Res 46:1460, 1985. PUBMED Abstract

  150. Henry D, Carless P, Fergusson D, et al: The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis. CMAJ 180:183, 2009. PUBMED Abstract

  151. Hermans PWM, Hazelzet JA: Plasminogen activator inhibitor type 1 gene polymorphism and sepsis. Clin Infect Dis 41:S453, 2005. PUBMED Abstract

  152. Hess JR, Brohi K, Dutton RP, et al: The coagulopathy of trauma: a review of mechanisms. J Trauma 65: 748, 2008. PUBMED Abstract

  153. Hirsh J: Heparin. N Engl J Med 324:1565, 1991. PUBMED Abstract

  154. Hirsh J, Raschke R: Heparin and low-molecular-weight heparin: the seventh AACCP conference on antithrombotic and thrombolytic therapy. Chest 126:188S, 2004. PUBMED Abstract

  155. Ho AM, Karmakar MK, Dion PW: Are we giving enough coagulation factors during major trauma resuscitation? Am J Surg 190:479, 2005. PUBMED Abstract

  156. Hoffman M, Monroe DM: A cell-based model of hemostasis. Thromb Haemost 85:958, 2001. PUBMED Abstract

  157. Hoffmann JN, Vollmar B, Laschke MW, et al: Adverse effect of heparin on antithrombin action during endotoxemia: microhemodynamic and cellular mechanisms. Thromb Haemost 88:242, 2002. PUBMED Abstract

  158. Hogan DF, Dhaliwal RS, Sisson DD, et al: Paraneoplastic thrombocytosis-induced systemic thromboembolism in a cat. J Am Anim Hosp Assoc 35:483, 1999. PUBMED Abstract

  159. Hogan DF, Andrews DA, Green HW, et al: Antiplatelet effects and pharmacodynamics of clopidogrel in cats. J Am Vet Med Assoc 225:1406, 2004. PUBMED Abstract

  160. Holcomb JB, Jenkins D, Rhee P, et al: Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma 62: 307, 2007. PUBMED Abstract

  161. Holcomb JB, Wade CE, Michalek JE, et al: Increased plasma and platelet to red blood cell ratios improves outcome in 466 civilian trauma patients. Ann Surg 248:447, 2008. PUBMED Abstract

  162. Hollopeter G, Jantzen HM, Vinvent D, et al: Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409:202, 2001. PUBMED Abstract

  163. Horrevoets AJG: Plasminogen activator inhibitor 1 (PAI-1): in vitro activities and clinical relevance. Br J Haematol 125:12, 2004.

  164. Hsu JT, Chu CM, Chang ST, et al: Prognostic role of arterial/alveolar oxygen tension ratio (a/APO2) in acute pulmonary embolism. Circ J 70:1611, 2006. PUBMED Abstract

  165. Hu KQ, Yu AS, Tiyyagura L, et al: Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit. Am J Gastroenterol 96:1581, 2001. PUBMED Abstract

  166. Hull R, Delmore T, Genton E, et al: Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. N Engl J Med 301:855, 1979. PUBMED Abstract

  167. Hull RD, Raskob GE, Brandt RF, et al: Relation between the time to achieve the lower limit of the aPTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis. Arch Intern Med 157:2562, 1997. PUBMED Abstract

  168. Hull RD, Pineo GF: Prophylaxis of deep venous thrombosis and pulmonary embolism: current recommendations. Med Clin N Am 82:477, 1998. PUBMED Abstract

  169. Hull R, Pineo GF, Mah A, et al: Safety and efficacy results for a study investigating the long-term out-of-hospital treatment of patients with proximal-vein thrombosis using subcutaneous low-molecular-weight heparin versus warfarin (abstract). Thromb Haemost 1(suppl 1):1647, 2001.

  170. Hyers TM, Agnelli G, Hull RD, et al: Antithrombotic therapy for venous thromboembolic disease: sixth ACCP consensus conference on antithrombotic therapy. Chest 119:176S, 2001.

  171. Iba T, Kidokoro A: What can we learn from the three megatrials using anticoagulants in severe sepsis? Shock 22:508, 2004. PUBMED Abstract

  172. Jergens AE, Turrentine MA, Kraus KH, et al: Buccal mucosal bleeding times of healthy dogs and of dogs in various pathologic states, including thrombocytopenia, uremia, and von Willebrand’s disease. Am J Vet Res 48:1337, 1987. PUBMED Abstract

  173. Jessen LR, Wiinberg B, Jensen AL, et al: In vitro heparinization of canine whole blood with low molecular weight heparin (dalteparin) significantly and dose-dependently prolongs heparinase-modified tissue factor-activated thromboelastography parameters and prothrombinase-induced clotting time. Vet Clin Pathol 37:363, 2008. PUBMED Abstract

  174. Jin RC, Voetch B, Loscalzo J: Endogenous mechanisms of inhibition of platelet function. Microcirculation 12:247, 2005. PUBMED Abstract

  175. Johansson PI: The blood bank: from provider to partner in treatment of massively bleeding patients. Transfusion 47:176S, 2007. PUBMED Abstract

  176. Johansson PI: Treatment of massively bleeding patients: introducing real-time monitoring, transfusion packages and thromboelastography (TEG). ISBT Science Series 2:159, 2007.

  177. Johnson LR, Lappin MR, Baker DC: Pulmonary thromboembolism in 29 dogs: 1985–1995. J Vet Intern Med 13:338, 1999. PUBMED Abstract

  178. Jordan HL, Grindem CB, Breitschwerdt EB: Thrombocytopenia in cats: a retrospective study of 41 cases. J Vet Intern Med 7:261, 1993. PUBMED Abstract

  179. Joseph RJ, Greenlee PG, Carrillo JM, et al: Canine cerebrovascular disease: clinical and pathological findings in 17 cases. J Am Anim Hosp Assoc 24:569, 1988.

  180. Jutkowitz LA, Rozanski EA, Moreau J, et al: Massive transfusion in dogs: 15 cases (1997–2002). J Am Vet Med Assoc 220:1664, 2002. PUBMED Abstract

  181. Kakkar AK, Haas S, Walsh D et al: Prevention of perioperative venous thromboembolism: outcome after cancer and non-cancer surgery (abstract). Thromb Haemost 86:OC1732, 2001.

  182. Kaneider NC, Forster E, Mosheimer B, et al: Syndecan-4–dependent signaling in the inhibition of endotoxin-induced endothelial adherence of neutrophils by antithrombin. Thromb Haemost 90:1150, 2003. PUBMED Abstract

  183. Kasper W, Meinertz T, Henkel B, et al: Echocardiographic findings in patients with proved pulmonary embolism. Am Heart J 112:1284, 1986. PUBMED Abstract

  184. Kaufman CR, Dwyer KM, Crews JD: Usefulness of thromboelastography in assessment of trauma patient coagulation. J Trauma Injury Infect Crit Care 42:716, 1997. PUBMED Abstract

  185. Kellerman DL, Lewis DC, Bruyette DS, et al: Determination and monitoring of a therapeutic heparin dosage in the dog (abstract). J Vet Intern Med 9:187, 1995.

  186. Kheirabadi BS, Crissey JM, Deguzman R, et al: Effects of synthetic versus natural colloid resuscitation on inducing dilutional coagulopathy and increasing hemorrhage in rabbits. J Trauma 64:1218, 2008. PUBMED Abstract

  187. Kheirabadi BS, Crissey JM, Deguzman R, et al: In vivo bleeding time and in vitro thromboelastography are better indicators of dilutional hypothermic coagulopathy than prothrombin time. J Trauma 62:1352, 2007. PUBMED Abstract

  188. Kienast J, Juers M, Wiedermann CJ, et al: Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost 4:90, 2006. PUBMED Abstract

  189. Kirby R, Rudloff E: Acquired coagulopathy VI: disseminated intravascular coagulation. In Schalm BF, Zinkl JG, Jain NC, editors: Schalm’s veterinary hematology, ed 5, Baltimore, 2000, Lippincott Williams and Wilkins, pp 581.

  190. Kitchen S, Preston FE: The therapeutic range for heparin therapy: relationship between six activated partial thromboplastin time reagents and two heparin assays. Thromb Haemost 75:734, 1996. PUBMED Abstract

  191. Klein MK, Dow SW, Rosychuk RAW: Pulmonary thromboembolism associated with immune-mediated hemolytic anemia in dogs: ten cases (1982–1987). J Am Vet Med Assoc 195:246, 1989. PUBMED Abstract

  192. Kluft C, Verheijen JH, Jie AF, et al: The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. Scand J Clin Lab Invest 45:605, 1985. PUBMED Abstract

  193. Knoll JS: Clinical automated haematology systems. In Feldman BF, Zinkl JG, Jain NJ, editors: Schalm’s veterinary hematology, ed 5, Philadelphia, 2000, Lippincott Williams and Wilkins, pp 3.

  194. Koblik PD, Hornof W, Harnagel SH, et al: A comparison of pulmonary angiography, digital subtraction angiography, and 99m Tc-DTCPA/MMA ventilation-perfusion scintigraphy for detection of experimental pulmonary emboli in the dog. Vet Radiol 30:159, 1989.

  195. Koch A, Ziegler S, Breitschwerdt H, et al: Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis: meta-analysis based on original patient data. Thromb Res 102:295, 2001. PUBMED Abstract

  196. Konstantinides S: The case for thrombolysis in acute major pulmonary embolism: hemodynamic benefits and beyond. Intensive Care Med 28:1547, 2002. PUBMED Abstract

  197. Kraus KH, Turrentine MA, Jergens AE, et al: Effect of desmopressin acetate on bleeding times and plasma von Willebrand factor in Doberman pinchers with vWD. Vet Surg 18:103, 1989. PUBMED Abstract

  198. Kristensen AT, Wiinberg B, Jenssen LR, et al: Evaluation of human recombinant tissue factor-activated thromboelastography in 49 dogs with neoplasia. J Vet Intern Med 22:140, 2008. PUBMED Abstract

  199. Kruithof EK, Gudinchet A, Bachmann F: Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states. Thromb Haemost 59:7, 1988. PUBMED Abstract

  200. Kujovich JL: Hemostatic defects in end stage liver disease. Crit Care Clinics 21:563, 2005. PUBMED Abstract

  201. Kummeling A, Teske E, Rothuizen J, et al: Coagulation profiles in dogs with congenital portosystemic shunts before and after surgical attenuation. J Vet Intern Med 20:1319, 2006. PUBMED Abstract

  202. Lanevschi-Pietersma C, Bedard L, Kohlbrenner L: D-dimer, thrombin-antithrombin complex and fibrinogen degradation product levels measured in dogs with different systemic diseases. Vet Clin Pathol 32:225, 2003.

  203. Lara-Garcia A, Coato CG, Iazbik MC, et al: Postoperative bleeding in retired racing greyhounds. J Vet Intern Med 22:525, 2008. PUBMED Abstract

  204. LaRue MJ, Murtaugh RJ: Pulmonary thromboembolism in dogs: 47 cases (1986–1987). J Am Anim Hosp Assoc 197:1368, 1990. PUBMED Abstract

  205. Laste N, Harpster N: A retrospective study of 100 cases of feline distal aortic thromboembolism: 1977–1993. J Am Anim Hosp Assoc 31:492, 1995. PUBMED Abstract

  206. Lawson JH, Murphy MP: Challenges for providing effective hemostasis in surgery and trauma. Semin Hematol 41:55, 2004. PUBMED Abstract

  207. Lee AY, Levine MN, Baker RI, et al: Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 349:146, 2003. PUBMED Abstract

  208. Leebeek FW, Kluft C, Knot EA, et al: A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis. Gastroenterology 101:1382, 1991. PUBMED Abstract

  209. Leese T, Holliday M, Watkins M, et al: A multicentre controlled clinical trial of high-volume fresh frozen plasma therapy in prognostically severe acute pancreatitis. Ann R Coll Surg Engl 73:207, 1991. PUBMED Abstract

  210. Levi M, ten Cate H: Disseminated intravascular coagulation. N Engl J Med 341:586, 1999. PUBMED Abstract

  211. Levi M, Peters M, Buller HR: Efficacy and safety of recombinant factor VIIa for the treatment of severe bleeding: a systematic review. Crit Care Med 33:883, 2005. PUBMED Abstract

  212. Levi M, van der Poll T: Two-way interactions between inflammation and coagulation. Trends Cardiovasc Med 15:254, 2005. PUBMED Abstract

  213. Levi M, Opal SM: Coagulation abnormalities in critically ill patients. Crit Care 10: 222, 2006. PUBMED Abstract

  214. Levi M: Disseminated intravascular coagulation. Crit Care Med 35:2191, 2007. PUBMED Abstract

  215. Levi M, Toh CH, Thachil J, et al: Guidelines for the diagnosis and management of disseminated intravascular coagulation: British committee for standards in haematology. Br J Haematol 145:24, 2009. PUBMED Abstract

  216. Levine M, Hirsh J, Gent M, et al: A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thrombosis requiring large daily doses of heparin. Arch Intern Med 154:49, 1994. PUBMED Abstract

  217. Lewis DC, Myers KM: Canine idiopathic thrombocytopenic purpura. J Vet Intern Med 10:207, 1996. PUBMED Abstract

  218. Lind SE: The bleeding time does not predict surgical bleeding. Blood 77:2547, 1991. PUBMED Abstract

  219. Lippi G, Franchini M: Pathogenesis of venous thromboembolism: when the cup runneth over. Semin Thromb Haemost 34:747, 2008. PUBMED Abstract

  220. Lisciandro SC, Hohenhaus A, Brooks M: Coagulation abnormalities in 22 cats with naturally occurring liver disease. J Vet Intern Med 12:71, 1998. PUBMED Abstract

  221. Liska WD, Poteet BA: Pulmonary embolism associated with canine total hip replacement. Vet Surg 32:178, 2003. PUBMED Abstract

  222. Litaker D: Preoperative screening. Med Clin N Am 83:1565, 1999. PUBMED Abstract

  223. Lunsford K, Mackin A, Langston C, et al: Pharmacokinetics of the biologic effects of subcutaneous enoxaparin in dogs (abstract). J Vet Intern Med 19:400, 2005.

  224. MacFarlane RG: An enzyme cascade in the blood clotting mechanism, and its function as a biologic amplifier. Nature 202:498, 1964. PUBMED Abstract

  225. Mackman N: Triggers, targets and treatments for thrombosis. Nature 451:914, 2008. PUBMED Abstract

  226. Macpherson DS, Snow R, Lofren RP: Preoperative screening: value of previous tests. Ann Intern Med 113:969, 1990. PUBMED Abstract

  227. Maddison JE, Watson AD, Eade IG, et al: Vitamin K–dependent multifactor coagulopathy in Devon Rex cats. J Am Vet Med Assoc 197:1495, 1990. PUBMED Abstract

  228. Mallet SV, Cox DJA: Thromboelastography. Br J Anaesth 69:307, 1992.

  229. Mannucci PM: Hemostatic drugs. N Engl J Med 339:245, 1998. PUBMED Abstract

  230. Marcus AJ, Broekman MJ, Drosopoulus JH, et al: The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 99:1351, 1997. PUBMED Abstract

  231. Marietta M, Facchini L, Pedrazzi P, et al: Pathophysiology of bleeding in surgery. Transplant Proc 38:812, 2006. PUBMED Abstract

  232. Marlar RA, Endres-Brooks J, Miller C: Serial studies of protein C and its plasma inhibitor in patients with disseminated intravascular coagulation. Blood 66:59, 1985. PUBMED Abstract

  233. Maroney SA, Mast AE: Expression of tissue factor pathway inhibitor by endothelial cells and platelets. Transfus Apher Sci 38:9, 2008. PUBMED Abstract

  234. Martin D, Boys C, Ruf W: Tissue factor: molecular recognition and cofactor function. FASEB J 9:852, 1995. PUBMED Abstract

  235. Martini WZ, Chinkes DL, Pusateri AE, et al: Acute changes in fibrinogen metabolism and coagulation after hemorrhage in pigs. Am J Physiol Endocrinol Metab 289:E930, 2005. PUBMED Abstract

  236. Martini WZ, Dubick MA, Wade CE, et al: Does bicarbonate correct coagulation function impaired by acidosis in swine? J Trauma 61:99, 2006. PUBMED Abstract

  237. Maruyama H, Miura T, Sakai M, et al: The incidence of disseminated intravascular coagulation in dogs with malignant tumor. J Vet Med Sci 66:573, 2003.

  238. McConnell MV, Solomon SD, Rayan ME, et al: Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. Am J Cardiol 78:469, 1996. PUBMED Abstract

  239. McGrath DJ, Cerboni E, Frumento RJ, et al: Thromboelastography maximal amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 100:1576, 2005. PUBMED Abstract

  240. McNeil EA, Ogilvie GK, Fettman MJ, et al: Platelet hyperfunction in dogs with malignancies. J Vet Intern Med 11:178, 1997. PUBMED Abstract

  241. McNicol A, Israels SJ: Platelets and anti-platelet therapy. J Pharmacol Sci 93:381, 2003. PUBMED Abstract

  242. Meng ZH, Wolberg AS, Monroe DM, III, et al: The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. J Trauma 55: 886, 2003. PUBMED Abstract

  243. Mikhailidis DP, Ganotakis ES: Plasma albumin and platelet function: relevance to atherogenesis and thrombosis. Platelets 7:125, 1996. PUBMED Abstract

  244. Miller RD, Robbins TO, Barton SL: Coagulation defects associated with massive transfusions. Ann Surg 174:794, 1971. PUBMED Abstract

  245. Mischke R, Nolte IJA: Hemostasis: introduction, overview, laboratory techniques. In Feldman BF, Zinkl JG, Jain NJ, editors: Schalm’s veterinary hematology, ed 5, Philadelphia, 2000, Lippincott Williams and Wilkins, pp 519.

  246. Mischke RH, Schuttert C, Grebe SI: Anticoagulant effects of repeated subcutaneous injections of high doses of unfractionated heparin in healthy dogs. Am J Vet Res 62:1887, 2001. PUBMED Abstract

  247. Mischke R, Jacobs C: The monitoring of heparin administration by screening tests in experimental dogs. Res Vet Sci 70:101, 2001. PUBMED Abstract

  248. Mischke R, Grebe S, Jacobs C, et al: Amidolytic heparin activity and values for several hemostatic variables after repeated subcutaneous administration of high doses of a low molecular weight heparin in healthy dogs. Am J Vet Res 62:595, 2001. PUBMED Abstract

  249. Mischke R: Alterations of the global haemostatic function test ‘resonance thrombography’ in spontaneously traumatized dogs. Pathophysiol Haemost Thromb 33: 214, 2003. PUBMED Abstract

  250. Mismetti P, Laporte S, Darmon JY, et al: Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg 88:913, 2001. PUBMED Abstract

  251. Mittermayr M, Streif W, Haas T, et al: Hemostatic changes after crystalloid or colloid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg 105:905, 2007. PUBMED Abstract

  252. Monroe DM, Hoffman M, Oliver JA, et al: Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol 99:542, 1997. PUBMED Abstract

  253. Moritz A, Walcheck BK, Weiss DJ: Evaluation of flow cytometric and automated methods for detection of activated platelets in dogs with inflammatory disease. Am J Vet Res 66:325, 2005. PUBMED Abstract

  254. Moser KM, Guisan M, Bartimmo EE, et al: In vivo and postmortem dissolution rates of pulmonary emboli and venous thrombi in the dog. Circulation 48:170, 1973. PUBMED Abstract

  255. Moser KM: Venous thromboembolism. Am J Rev Respir Dis 141:235, 1990. PUBMED Abstract

  256. Mosnier LO, Zlokovic BV, Griffin JH: The cytoprotective protein C pathway. Blood 109:3161, 2006. PUBMED Abstract

  257. Mount M: Diagnosis and therapy of anticoagulant rodenticide intoxications. Vet Clin North Am Small Anim Pract 18:115, 1988. PUBMED Abstract

  258. Murkin JM: Lessons learned in antifibrinolytic therapy: the BART trial. Semin Cardiothorac Vasc Anesth 13:127, 2009. PUBMED Abstract

  259. Nachman RL, Rafii S: Platelets, petechiae, and preservation of the vascular wall. N Engl J Med 359:1261, 2008. PUBMED Abstract

  260. Neel JA, Birkenheuer AJ, Grindem CB: Thrombocytopenia. In Bonagura JD, Twedt DC, editors: Kirk’s current veterinary therapy, ed 14, St Louis, 2009, Saunders Elsevier, pp 281.

  261. Neff-Davis CA, Davis LE, Gillette EL: Warfarin in the dog: pharmacokinetics as related to clinical response. J Vet Pharmacol Ther 4:135, 1981. PUBMED Abstract

  262. Nelson OL, Andreasen C: The utility of plasma D-dimer to identify thromboembolic disease in dogs. J Vet Intern Med 17:830, 2003. PUBMED Abstract

  263. Nesheim M: Thrombin and fibrinolysis. Chest 124:33S, 2003. PUBMED Abstract

  264. Newman GE: Pulmonary angiography in pulmonary embolic disease. J Thorac Imaging 4:28, 1989. PUBMED Abstract

  265. Ngyuyen TC, Carcillo JA: Bench-to-bedside review: thrombocytopenia-associated multiple organ failure—a newly appreciated syndrome in the critically ill. Crit Care 10:235, 2006. PUBMED Abstract

  266. Nielsen VG, Cohen BM, Cohen E: Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thromboelastography: critical roles of fibrinogen and factors II, VII, X and XII. Acta Anaesthesiol Scand 49:222, 2005. PUBMED Abstract

  267. Nielsen VG, Levy JH: Fibrinogen and bleeding: old molecule—new ideas. Anesth Analg 105:902, 2007. PUBMED Abstract

  268. Norman EJ, Barron RC, Nash AS, et al: Prevalence of low automated platelet counts in cats: comparison with prevalence of thrombocytopenia based on blood smear estimation. Vet Clin Pathol 30:137, 2001. PUBMED Abstract

  269. Norris CR, Griffey SM, Samii VF: Pulmonary thromboembolism in cats: 29 cases (1987–1997). J Am Vet Med Assoc 215:1650, 1999. PUBMED Abstract

  270. Novo Nordisk: Recombinant factor VIIa, product package insert. Bagsvaerd, Denmark: Novo Nordisk A/S.

  271. Oelschlager C, Romisch J, Staubitz A, et al: Antithrombin III inhibits nuclear factor kappaB activation in human monocytes and vascular endothelial cells. Blood 99:4015, 2002. PUBMED Abstract

  272. Olsson P, Lagergren H, Ek S: The elimination from plasma of intravenous heparin: an experimental study on dogs and humans. Acta Med Scand 173:619, 1963. PUBMED Abstract

  273. Orcutt ES, Polzin DJ, Armstrong PJ, et al: Comparison of individually monitored unfractionated heparin versus low-dose aspirin on survival of dogs with immune-mediated hemolytic anemia (abstract). J Vet Intern Med 23:692, 2009.

  274. Otto CM, Rieser TM, Brooks MB, et al: Evidence of hypercoagulability in dogs with parvoviral enteritis. J Am Vet Med Assoc 217:1500, 2000. PUBMED Abstract

  275. Owings JT, Gosselin RC: Bleeding and transfusion. In Wilmore WW, Chueng LY, Harken AH, et al, editors: American College of Surgeons surgery principles and practice, Chicago, 2001, American College of Surgeons, pp 77.

  276. Palmer AJ, Schramm W, Kirchhof B, et al: Low molecular weight heparin and unfractionated heparin for prevention of thrombo-embolism in general surgery: a meta-analysis of randomized clinical trials, Haemostasis 27:65, 1997. PUBMED Abstract

  277. Palmer KG, King LG, Van Winkle TJ: Clinical manifestations and associated disease syndromes in dogs with cranial vena cava thrombosis: 17 cases (1989–1996). J Am Vet Med Assoc 213:220, 1998. PUBMED Abstract

  278. Patrono C, Bachman F, Baigent C, et al: Expect consensus document on the use of antiplatelet drugs. Eur Heart J 25:166, 2004.

  279. Patrono C, Coller B, Fitzgerald GA, et al: Platelet-active drugs: the relationships among dose, effectiveness, and side effects: seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:234S, 2004. PUBMED Abstract

  280. PEP investigators: Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 355:1295, 2000.

  281. Peterson JL, Couto CG, Wellman ML: Hemostatic disorders in cats: a retrospective study and review of the literature. J Vet Intern Med 9:298, 1995. PUBMED Abstract

  282. Pfanner G, Koscielny J, Pernerstorter T, et al: Preoperative evaluation of the bleeding history: recommendations of the working group on perioperative coagulation of the Austrian Society for Anesthesia, Resuscitation and Intensive Care. Anesthetist 56:604, 2007. PUBMED Abstract

  283. Piek CJ, Junius G, Dekker A, et al: Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs. J Vet Intern Med 22:366, 2008. PUBMED Abstract

  284. Pineo GF, Hull RD: Unfractionated and low-molecular-weight heparin: comparisons and current recommendations. Med Clin N Am 82:587, 1998. PUBMED Abstract

  285. Pouchelon JL, Chetboul V, Devauchelle P, et al: Diagnosis of pulmonary thromboembolism in a cat using echocardiography and pulmonary scintigraphy. J Small Anim Pract 3:306, 1997. PUBMED Abstract

  286. Prater MR: Acquired coagulopathy, I: avitaminosis K. In Feldman BF, Zinkl JG, Jain NC, editors: Schalm’s veterinary hematology, ed 5, Philadelphia, 2000, Lippincott Williams and Wilkins, pp 556.

  287. Prater MR: Acquired coagulopathy, II: liver disease. In Feldman BF, Zinkl JG, Jain NC, editors: Schalm’s veterinary hematology, ed 5, Philadelphia, 2000, Lippincott Williams and Wilkins, pp 560.

  288. Prins M, Schellens CJMM, van Leeuwen MW, et al: Coagulation disorders in dogs with hepatic disease. Vet J 185:163, 2010. PUBMED Abstract

  289. Pulletz S, Lehmann C, Volk T, et al: Influence of heparin and hirudin on endothelial binding of antithrombin in experimental thrombinemia. Crit Care Med 28:2881, 2000. PUBMED Abstract

  290. Quinlan DJ, McQuillan A, Eikenboom JW: Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials. Ann Intern Med 140:175, 2004. PUBMED Abstract

  291. Rackear D, Feldman B, Farver T, et al: The effect of three different dosages of acetylsalicylic acid on canine platelet aggregation. J Am Anim Hosp Assoc 24:23, 1988.

  292. Raschke RA, Reilly BM, Fontana JR, et al: The weight-based heparin dosing normogram compared with a “standard care” nomogram: a randomized controlled trial. Ann Intern Med 119:874, 1993. PUBMED Abstract

  293. Rathbun SW, Raskob GE, Whittset TL: Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: a systematic review. Ann Intern Med 132:227, 2000. PUBMED Abstract

  294. Rau JC, Beaulieu LM, Huntington JA, et al: Serpins in thrombosis, hemostasis and fibrinolysis. J Thromb Haemost 5(suppl 1):102, 2007. PUBMED Abstract

  295. Raymond SL, Jones DW, Brooks M, et al: Clinical and laboratory features of a severe form of von Willebrand disease in Shetland sheepdogs. J Am Vet Med Assoc 197:1342, 1990. PUBMED Abstract

  296. Reade MS, Reddick RL, Bode AP, et al: Preservation of hemostatic and structural properties of rehydrated lyophilized platelets: potential for long-term storage of dried platelets for transfusion. Proc Natl Acad Sci U S A 92:397, 1995. PUBMED Abstract

  297. Rebulla P, Finazzi G, Marangoni F, et al: The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia: gruppo Italiano malattie ematologiche maligne dell’adulto. N Engl J Med 337:1870, 1997. PUBMED Abstract

  298. Ribeiro A, Lindmarker P, Juhlin-Dannfelt A, et al: Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rate. Am Heart J 134:479, 1997. PUBMED Abstract

  299. Ribeiro A, Juhlin-Dannfelt A, Brodin LA, et al: Pulmonary embolism: relation between the degree of right ventricular overload and the extent of perfusion defects. Am Heart J 135:868, 1998. PUBMED Abstract

  300. Roberts HR, Monroe DM, White GC: The use of recombinant factor VIIa in the treatment of bleeding disorders. Blood 104:3858, 2004. PUBMED Abstract

  301. Roberts HR, Hoffman M, Monroe DM: A cell-based model of thrombin generation. Semin Thromb Hemost 32:32, 2006. PUBMED Abstract

  302. Roderick PJ, Wilkes HC, Meade TW: The gastrointestinal toxicity of aspirin: an overview of randomized controlled trials. Br J Clin Pharmacol 35:219, 1993. PUBMED Abstract

  303. Rogers CL, O’Toole TE, Keating JH, et al: Portal vein thrombosis in cats: 6 cases (2001–2006). J Vet Intern Med 22:282, 2008. PUBMED Abstract

  304. Rozanski EA, Hughes D, Scotti M, et al: The effect of heparin and fresh frozen plasma on plasma antithrombin III activity, prothrombin time and activated partial thromboplastin time in critically ill dogs. J Vet Emerg Crit Care 11:15, 2001.

  305. Rudloff E, Kirby R: Disseminated intravascular coagulation: diagnosis and management. In Bonagura JD, Twedt DC, editors: Kirk’s current veterinary therapy, ed 14, St Louis, 2009, Saunders Elsevier, pp 287.

  306. Rush JE, Freeman LM, Fenollosa NK, et al: Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990–1999). J Am Vet Med Assoc 220:202, 2002. PUBMED Abstract

  307. Russell KE, Grindem CB: Secondary thrombocytopenia. In Feldman BF, Zinkl JG, Jain NC, editors: Schalm’s veterinary hematology, ed 5, Philadelphia, 2000, Lippincott Williams and Wilkins, pp 487.

  308. Rutherford EJ, Morris JA, Reed GW, et al: Base deficit stratifies mortality and determines therapy. J Trauma 33:417, 1992. PUBMED Abstract

  309. Sadler JE, Matsushita T, Dong Z, et al: Molecular mechanism and classification of von Willebrand disease. Thromb Haemost 74:161, 1995. PUBMED Abstract

  310. Sato I, Anderson GA, Parry BW: An interobserver and intraobserver study of buccal mucosal bleeding time in greyhounds. Res Vet Sci 68:41, 2000. PUBMED Abstract

  311. Schafer AI: The hypercoagulable states. Ann Intern Med 102:814, 1985. PUBMED Abstract

  312. Schermerhorn T, Pembleton-Corbett JR, Kornreich B: Pulmonary thromboembolism in cats. J Vet Intern Med 18:533, 2004. PUBMED Abstract

  313. Schoeman JP: Feline distal aortic thromboembolism: a review of 44 cases (1990–1998). J Feline Med Surg 1:221, 1999. PUBMED Abstract

  314. Schouten ES, van de Pol AC, Schouten AN, et al: The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: a meta-analysis. Pediatr Crit Care Med 10:182, 2009. PUBMED Abstract

  315. Scott KC, Hansen BD, DeFrancesco TC: Coagulation effects of low molecular weight heparin compared with heparin in dogs considered to be at risk for clinically significant venous thrombosis. J Vet Emerg Crit Care 19:74, 2009. PUBMED Abstract

  316. Scott MA: Immune-mediated thrombocytopenia. In Feldman BF, Zinkl JG, Jain NC, editors: Schalm’s veterinary hematology, ed 5, Philadelphia, 2000, Lippincott Williams and Wilkins, pp 478.

  317. Scott-Montcrief JC, Treadwell NG, McCullough SM, et al: Hemostatic abnormalities in dogs with primary immune-mediated hemolytic anemia. J Am Anim Hosp Assoc 37:220, 2001. PUBMED Abstract

  318. Segal JB, Dzik WH: Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion 45:1404, 2005. PUBMED Abstract

  319. Seki Y, Machida N, Arimura T, et al: Transmural myocardial infarction caused by thromboembolism associated with mitral insufficiency in a dog. J Vet Med Sci 60:741, 1998. PUBMED Abstract

  320. Séverine T, Cripps PJ, Mackin AJ: Estimation of platelet counts on feline blood smears. Vet Clin Pathol 28:42, 1999. PUBMED Abstract

  321. Shore-Lesserson L, Manspeiser HE, DePerio M, et al: Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 88:312, 1999. PUBMED Abstract

  322. Simons R, Mallett SV: Use of thromboelastography to demonstrate persistent anticoagulation after stopping enoxaparin. Anaesthesia 62:1175, 2007. PUBMED Abstract

  323. Slichter SJ: Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients. J Clin Apheresis 21:78, 2006. PUBMED Abstract

  324. Smedile LE, Houston DM, Taylor SM, et al: Idiopathic asymptomatic thrombocytopenia in Cavalier King Charles spaniels: 11 cases (1983–1993). J Am Anim Hosp Assoc 33:411, 1997. PUBMED Abstract

  325. Smetana GW, Macpherson DS: The case against routine preoperative laboratory testing. Med Clin North Am 87:7, 2003. PUBMED Abstract

  326. Smith SA, Lewis DC, Kellerman DL: Adjustment of intermittent subcutaneous heparin therapy based on chromogenic heparin assay in 9 cats with thromboembolism (abstract). In Proceedings of the 16th ACVIM Forum, San Diego, CA, 1998, American College of Veterinary Internal Medicine.

  327. Smith SA, Tobias AH, Jacob KA, et al: Arterial thromboembolism in cats: acute crisis in 127 cases (1992–2001) and long-term management with low-dose aspirin in 24 cases. J Vet Intern Med 17:73, 2003. PUBMED Abstract

  328. Smith SA, Tobias AH: Feline arterial thromboembolism: an update. Vet Clin North Am Small Anim Pract 34:1245, 2004b. PUBMED Abstract

  329. Sobieszczyk P, Fishbein M, Goldhaber SZ: Acute pulmonary thromboembolism: don’t ignore the platelet. Circulation 106:1748, 2002. PUBMED Abstract

  330. Stein SC, Smith DH: Coagulopathy in traumatic brain injury. Neurocrit Care 1:479, 2004. PUBMED Abstract

  331. Stein PD, Woodard PK, Weg JG, et al: Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II investigators. Radiology 242:15, 2007. PUBMED Abstract

  332. Stokol T, Parry BW: Efficacy of fresh-frozen plasma and cryoprecipitate in dogs with von Willebrand’s disease or hemophilia A. J Vet Intern Med 12:84, 1998. PUBMED Abstract

  333. Stokol T, Brooks M, Erb H, et al: Evaluation of kits for the detection of fibrin(ogen) degradation products in dogs. J Vet Intern Med 13:478, 1999. PUBMED Abstract

  334. Stokol T, Brooks MB, Erb HN, et al: D-dimer concentrations in healthy dogs and dogs with disseminated intravascular coagulation. Am J Vet Res 61:393, 2000. PUBMED Abstract

  335. Stokol T: Plasma D-dimer for the diagnosis of thromboembolic disorders in dogs. Vet Clin North Am Small Anim Pract 33:1419, 2003. PUBMED Abstract

  336. Stokol T, Brooks M: Editorial: Diagnosis of DIC in cats: is it time to go back to the basics? J Vet Intern Med 20:1289, 2006. PUBMED Abstract

  337. Strauss R, Wehler M, Mehler K, et al: Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med 30:1765, 2002. PUBMED Abstract

  338. Suter PF: Thoracic radiography: a text atlas of thoracic diseases of the dog and cat, Basel, Switzerland, 1984, Wettswil.

  339. Sykes JE, Kittleson MD, Chomel BB, et al: Clinicopathologic findings and outcome in dogs with infective endocarditis: 71 cases (1992–2005). J Am Vet Med Assoc 228:1735, 2006. PUBMED Abstract

  340. Takagi H, Manabe H, Kawai N, et al: Aprotinin increases mortality as compared with tranexamic acid in cardiac surgery: a meta-analysis of randomized head-to-head trials. Interact Cardiovasc Thorac Surg 9:98, 2009. PUBMED Abstract

  341. Taylor FB, Toh CH, Hoots WK, et al: Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86:1327, 2001. PUBMED Abstract

  342. Ten Cate H, Schoenmakers SH, Franco R, et al: Microvascular coagulopathy and disseminated intravascular coagulation. Crit Care Med 29:S95, 2001. PUBMED Abstract

  343. Theroux P, Waters D, Latn J, et al: Reactivation of unstable angina after the discontinuation of heparin. N Engl J Med 327:141, 1992. PUBMED Abstract

  344. Tholen I, Weingart C, Kohn B: Concentration of D-dimers in healthy cats and sick cats with and without disseminated intravascular coagulation. J Feline Med Surg 11:842, 2009. PUBMED Abstract

  345. Thomas JS, Green RA: Clotting times and antithrombin III activity in cats with naturally developing diseases: 85 cases (1984–1994). J Am Vet Med Assoc 213:1290, 1998. PUBMED Abstract

  346. Thomas JS, Rogers KS: Platelet aggregation and adenosine triphosphate secretion in dogs with untreated multicentric lymphoma. J Vet Intern Med 13:319, 1999. PUBMED Abstract

  347. Thompson MF, Scott-Montcrief JC, Brooks MB: Effect of a single plasma transfusion on thromboembolism in 13 dogs with primary immune-mediated hemolytic anemia. J Am Anim Hosp Assoc 40:446, 2004. PUBMED Abstract

  348. Tidwell SA, Graham JP, Peck JN, et al: Incidence of pulmonary embolism after non-cemented total hip arthroplasty in eleven dogs: computed tomographic pulmonary angiography and pulmonary perfusion scintigraphy. Vet Surg 36:37, 2007. PUBMED Abstract

  349. Traverso CI, Caprini JA, Arceles JI: Application of thromboelastography in other medical and surgical states. Semin Thromb Haemost 21:50, 1995. PUBMED Abstract

  350. Triplett DA: Current recommendations for warfarin therapy: use and monitoring. Med Clin North Am 82:601, 1988.

  351. Tseng LW, Hughes D, Giger U: Evaluation of a point-of-care coagulation analyzer for measurement of prothrombin time, activated partial thromboplastin time, and activated clotting time in dogs. Am J Vet Res 62:1455, 2001. PUBMED Abstract

  352. Valeri CR, Cassidy G, Pivacek LE, et al: Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss. Transfusion 41:977, 2001. PUBMED Abstract

  353. Valeri CR, Khuri S, Ragno G: Nonsurgical bleeding diathesis in anemic thrombocytopenic patients: role of temperature, red blood cells, platelets, and plasma-clotting proteins. Transfusion 47:206S, 2007. PUBMED Abstract

  354. Vanderschueren S, De Weerdt A, Malbrain M, et al: Thrombocytopenia and prognosis in intensive care. Crit Care Med 28:1871, 2000. PUBMED Abstract

  355. Van Winkle TJ, Bruce E: Thrombosis of the portal vein in 11 dogs. Vet Pathol 30:28, 1993. PUBMED Abstract

  356. Van Winkle TJ, Hackner SG, Liu SM: Clinical and pathologic features of aortic thromboembolism in 36 dogs. J Vet Emerg Crit Care 3:13, 1994.

  357. Vaya A, Mira Y, Martinez M, et al: Biological risk factors for deep vein thrombosis. Clin Hemorheol Microcirc 26:41, 2002. PUBMED Abstract

  358. Veres G, Radovitis T, Schultz H, et al: Effect of recombinant aprotinin on postoperative blood loss and coronary vascular function in a canine model of cardiopulmonary bypass. Eur J Cardiothorac Surg 32:340, 2007. PUBMED Abstract

  359. Vilar P, Couto CG, Westendorf N, et al: Thromboelastographic tracings in retired racing greyhounds and in non-greyhound dogs. J Vet Intern Med 22:374, 2008. PUBMED Abstract

  360. Vilar P, Ball R, Westendorf N, et al: Hemostatic effects of cryoprecipitate in dogs with disseminated intravascular coagulation (abstract). J Vet Intern Med 23:692, 2009.

  361. Virchow R: Phlogose und thrombose im gefä↓system: gesammelte abhandlungen zur wissenschaftlichen medizin, Frankfurt, 1856, Staatsdruckerei.

  362. Wagg CR, Boysen SR, Bedard C: Thromboelastography in dogs admitted to an intensive care unit. Vet Clin Pathol 28:453, 2009. PUBMED Abstract

  363. Wallack ST, Hornof WJ, Herrgessell EJ: Ultrasonographic diagnosis—small bowel infarction in a cat. Vet Radiol Ultrasound 44:81, 2003. PUBMED Abstract

  364. Warren DF, Turner DM, Kelly JD: Postoperative pulmonary embolism in the dog. Aust Vet J 46:277, 1970. PUBMED Abstract

  365. Warren BL, Eid A, Singer P, et al: Caring for the critically ill patient: high-dose antithrombin III in severe sepsis, a randomized controlled trial. JAMA 286:1869, 2001. PUBMED Abstract

  366. Webster CL: History, clinical signs, and physical findings in hepatobiliary disease. In Ettinger SJ, Feldman EC, editors: Textbook of veterinary internal medicine, ed 6, St Louis, 2005, Elsevier Saunders, pp 1422.

  367. Weinkle TK, Center SA, Randolph JF, et al: Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993–2002). J Am Vet Med Assoc 11:1869, 2005. PUBMED Abstract

  368. Weiss DJ, Brazzell JL: Detection of activated platelets in dogs with primary immune-mediated hemolytic anemia. J Vet Intern Med 20:682, 2006. PUBMED Abstract

  369. White HD: Comparative safety of thrombolytic agents. Am J Cardiol 69:12A, 1992.

  370. Wiedermann CJ, Romisch J: The antiinflammatory actions of antithrombin: a review. Acta Med Austriaca 29:89, 2002.

  371. Wiinberg B, Jensen AL, Rojkjaer R, et al: Validation of human recombinant tissue factor-activated thromboelastography on citrated whole blood from clinically healthy dogs. Vet Clin Pathol 34:389, 2005. PUBMED Abstract

  372. Wiinberg B, Jensen AL, Rozanski E, et al: Tissue factor activated thromboelastography correlates to clinical signs of bleeding in dogs. Vet J 179:121, 2007. PUBMED Abstract

  373. Wiinberg B, Jensen AL, Johansson PI, et al. Thromboelastographic evaluation of hemostatic function in dogs with disseminated intravascular coagulation. J Vet Intern Med 22:357, 2008. PUBMED Abstract

  374. Wiinberg B, Jensen AL, Johansson PI, et al: Development of a model based scoring system for diagnosis of canine disseminated intravascular coagulation with independent assessment of sensitivity and specificity. Vet J 2009 July 6. [Epub ahead of print] PUBMED Abstract

  375. Willis SE, Jackson ML, Meric SM, et al: Whole blood platelet aggregation in dogs with liver disease. Am J Vet Res 50:1893, 1989. PUBMED Abstract

  376. Wolberg AS, Meng ZH, Monroe DM, et al: A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function. J Trauma 56:1221, 2004. PUBMED Abstract

  377. Young E, Podor TJ, Venner T, et al: Induction of the acute-phase reaction increases heparin-binding proteins in plasma. Arterioscler Thromb Vasc Biol 17:1568, 1997. PUBMED Abstract

  378. Zeerleder S, Hack E, Wuillemin WA: Disseminated intravascular coagulation in sepsis. Chest 128:2864, 2009.

  379. Zimmerman KL: Drug-induced thrombocytopenias. In Feldman BF, Zinkl JG, Jain NC, editors: Schalm’s veterinary hematology, ed 5, Philadelphia, 2000, Lippincott Williams and Wilkins, pp 472.

  380. Zimmerman LH: Causes and consequences of critical bleeding and mechanisms of blood coagulation. Pharmacotherapy 27:45S, 2007. PUBMED Abstract

  381. Zmuda K, Neofotistos D, Ts’ao CH: Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation. Am J Clin Pathol 113:725, 2000. PUBMED Abstract

  382. Zorio E, Gilabert-Estelles J, Espana F, et al: Fibrinolysis: the key to new pathogenetic mechanisms. Curr Med Chem 15:923, 2008.

1   2   3   4   5   6   7   8   9   ...   55

Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©atelim.com 2016
rəhbərliyinə müraciət